We are live on ! Find out more
DTIL icon

Precision BioSciences

128 hedge funds and large institutions have $313M invested in Precision BioSciences in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

36% more capital invested

Capital invested by funds: $231M → $313M (+$82M)

8% more funds holding

Funds holding: 118128 (+10)

0.01% more ownership

Funds ownership: 1.76%1.77% (+0.01%)

6% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.32M

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
128
Holders Change
+10
Holders Change %
+8.47%
% of All Funds
2.25%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
25
Increased
45
Reduced
31
Closed
14
Calls
$1.24M
Puts
$1.32M
Net Calls
-$78K
Net Calls Change
-$27K
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$53.3M +$29.9M +85,428 +99%
BlackRock
2
BlackRock
New York
$43.5M +$2.16M +6,166 +5%
Capital World Investors
3
Capital World Investors
California
$42M
ACH
4
ArrowMark Colorado Holdings
Colorado
$24.8M -$12.6K -36 -0%
Vanguard Group
5
Vanguard Group
Pennsylvania
$23.9M -$1.46M -4,182 -5%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$8.42M -$3.43M -9,789 -27%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$7.46M +$869K +2,482 +12%
CA
8
CHI Advisors
New York
$7.16M -$1.88M -5,358 -19%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$6.51M +$7.34M +20,956 New
Morgan Stanley
10
Morgan Stanley
New York
$5.57M +$4.57M +13,061 +267%
Millennium Management
11
Millennium Management
New York
$5.32M -$689K -1,967 -10%
Northern Trust
12
Northern Trust
Illinois
$5.13M -$251K -717 -4%
Principal Financial Group
13
Principal Financial Group
Iowa
$4.34M +$372K +1,063 +8%
MSAM
14
Moloney Securities Asset Management
Missouri
$4.28M +$834K +2,381 +21%
Citigroup
15
Citigroup
New York
$4.05M +$4.17M +11,900 +1,032%
CAM
16
Cormorant Asset Management
Massachusetts
$3.59M
UBS Group
17
UBS Group
Switzerland
$3.42M +$2.26M +6,450 +142%
SCM
18
Sio Capital Management
New York
$3.41M +$137K +391 +4%
Charles Schwab
19
Charles Schwab
California
$3.09M +$76.7K +219 +2%
Rafferty Asset Management
20
Rafferty Asset Management
New York
$2.93M +$3.01M +8,598 +1,035%
Voloridge Investment Management
21
Voloridge Investment Management
Florida
$2.47M +$1.96M +5,612 +240%
Citadel Advisors
22
Citadel Advisors
Florida
$2.37M -$14.9M -42,582 -85%
LCM
23
Laurion Capital Management
New York
$2.35M
JP Morgan Chase
24
JP Morgan Chase
New York
$2.1M +$771K +2,201 +48%
GTC
25
Ghost Tree Capital
New York
$2.07M +$2.33M +6,667 New

DTIL Hedge Fund Activity: Q1 2021 in Review

128 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2021, worth a combined $313M — up 36% from $231M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DTIL positions and 14 closed out — a net gain of 11 holders — while 45 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $29.9M. The largest seller was Citadel Advisors, cutting an estimated $14.9M.

  • 128 institutional investors held Precision BioSciences (DTIL) as of Q1 2021, up from 118 in Q4 2020.
  • Funds reported $313M of Precision BioSciences stock for Q1 2021, up 36% quarter-over-quarter.
  • 25 funds opened new Precision BioSciences positions in Q1 2021 and 14 closed out, a net change of +11 holders.
  • The largest Precision BioSciences buyer in Q1 2021 was State Street, an estimated $29.9M added.
  • The largest Precision BioSciences seller in Q1 2021 was Citadel Advisors, an estimated $14.9M sold.

Based on aggregated 13F filings for Q1 2021.